Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nufail Khan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
IUBMB Life|February 25, 2012
IAPS and ubiquitylationRebecca Feltham, Nufail Khan, John Silke
International Journal of Environmental Research and Public Health|April 25, 2019
A Pest to Mental Health? Exploring the Link between Exposure to Agrichemicals in Farmers and Mental HealthNufail Khan, Alison Kennedy, Jacqueline Cotton, et al.
Current Opinion in Immunology|February 22, 2014
More to life than death: molecular determinants of necroptotic and non-necroptotic RIP3 kinase signalingNufail Khan, Kate E Lawlor, James M Murphy, et al.
Plos One|January 12, 2010
TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPLJosep Maria Lluis, Ulrich Nachbur, Wendy Diane Cook, et al.
Cell|November 21, 2007
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosisJames E Vince, W Wei-Lynn Wong, Nufail Khan, et al.
Cell Death and Differentiation|January 21, 2017
Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathwaysMaria C Tanzer, Nufail Khan, James A Rickard, et al.
Nature Communications|February 19, 2015
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLKate E Lawlor, Nufail Khan, Alison Mildenhall, et al.
Journal of Medicinal Chemistry|April 2, 2014
Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignanciesStephen M Condon, Yasuhiro Mitsuuchi, Yijun Deng, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
IUBMB Life|February 25, 2012
IAPS and ubiquitylationRebecca Feltham, Nufail Khan, John Silke
International Journal of Environmental Research and Public Health|April 25, 2019
A Pest to Mental Health? Exploring the Link between Exposure to Agrichemicals in Farmers and Mental HealthNufail Khan, Alison Kennedy, Jacqueline Cotton, et al.
Current Opinion in Immunology|February 22, 2014
More to life than death: molecular determinants of necroptotic and non-necroptotic RIP3 kinase signalingNufail Khan, Kate E Lawlor, James M Murphy, et al.
Plos One|January 12, 2010
TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPLJosep Maria Lluis, Ulrich Nachbur, Wendy Diane Cook, et al.
Cell|November 21, 2007
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosisJames E Vince, W Wei-Lynn Wong, Nufail Khan, et al.
Cell Death and Differentiation|January 21, 2017
Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathwaysMaria C Tanzer, Nufail Khan, James A Rickard, et al.
Nature Communications|February 19, 2015
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLKate E Lawlor, Nufail Khan, Alison Mildenhall, et al.
Journal of Medicinal Chemistry|April 2, 2014
Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignanciesStephen M Condon, Yasuhiro Mitsuuchi, Yijun Deng, et al.
Pageof 1